11th Circ. Won't Rehear FTC Androgel Pay-For-Delay Case
The Eleventh Circuit refused Wednesday to reconsider its decision nixing the Federal Trade Commission's antitrust challenge to patent settlements Solvay Pharmaceuticals Inc. inked with several generics makers to protect its blockbuster...To view the full article, register now.
Already a subscriber? Click here to view full article